Abstract

BackgroundThe aim of this study was to analyze the relative frequency, clinical characteristics, disease onset and progression in f-IPF vs. sporadic IPF (s-IPF).MethodsFamilial IPF index patients and their family members were recruited into the European IPF registry/biobank (eurIPFreg) at the Universities of Giessen and Marburg (UGMLC). Initially, we employed wide range criteria of f-IPF (e.g. relatives who presumably died of some kind of parenchymal lung disease). After narrowing down the search to occurrence of idiopathic interstitial pneumonia (IIP) in at least one first grade relative, 28 index patients were finally identified, prospectively interviewed and examined. Their family members were phenotyped with establishment of pedigree charts.ResultsWithin the 28 IPF families, overall 79 patients with f-IPF were identified. In the same observation period, 286 f-IIP and s-IIP patients were recruited into the eurIPFreg at our UGMLC sites, corresponding to a familial versus s-IPF of 9.8%. The both groups showed no difference in demographics (61 vs. 79% males), smoking history, and exposure to any environmental triggers known to cause lung fibrosis. The f-IPF group differed by an earlier age at the onset of the disease (55.4 vs. 63.2 years; p < 0.001). On average, the f-IPF patients presented a significantly milder extent of functional impairment at the time point of inclusion vs. the s-IPF group (FVC 75% pred. vs. FVC 62% pred., p = 0.011). In contrast, the decline in FVC was found to be faster in the f-IPF vs. the s-IPF group (4.94% decline in 6 months in f-IPF vs. 2.48% in s-IPF, p = 0.12). The average age of death in f-IPF group was 67 years vs. 71.8 years in s-IPF group (p = 0.059). The f-IIP group displayed diverse inheritance patterns, mostly autosomal-dominant with variable penetrance. In the f-IPF, the younger generations showed a tendency for earlier manifestation of IPF vs. the older generation (58 vs. 66 years, p = 0.013).ConclusionsThe 28 f-IPF index patients presented an earlier onset and more aggressive natural course of the disease. The disease seems to affect consecutive generations at a younger age.Trial registrationNr. NCT02951416http://www.www.clinicaltrials.gov

Highlights

  • The aim of this study was to analyze the relative frequency, clinical characteristics, disease onset and progression in form of Idiopathic Pulmonary Fibrosis (IPF) (f-IPF) vs. sporadic IPF (s-IPF)

  • Around 80% of all patients with familial idiopathic interstitial pneumonia (f-IIP) receive the diagnosis IPF, about 10% of fIIP patients might have the diagnosis of nonspecific interstitial pneumonia (NSIP) and another 10% of IIP patients stays as unclassifiable IIP or diagnoses split between remaining IIP entities [10,11,12]

  • The IPF diagnosis was done in accordance with an Official ATS/ERS/JRS/ ALAT Clinical Practice Guideline 2011 [32]

Read more

Summary

Introduction

The aim of this study was to analyze the relative frequency, clinical characteristics, disease onset and progression in f-IPF vs. sporadic IPF (s-IPF). Idiopathic Pulmonary Fibrosis (IPF) is a specific form of chronic, progressive fibrosing idiopathic interstitial pneumonia (IIP), a subgroup of diffuse parenchymal lung diseases (DPLD). In families of IPF patients, 2 to 20% of subjects reported to have a first degree relative with DPLD [7, 8]. Around 80% of all patients with familial idiopathic interstitial pneumonia (f-IIP) receive the diagnosis IPF, about 10% of fIIP patients might have the diagnosis of NSIP and another 10% of IIP patients stays as unclassifiable IIP or diagnoses split between remaining IIP entities [10,11,12]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.